Results 101 to 110 of about 11,874 (152)

Immunogenicity of Hepatitis B Virus Vaccination in Relapsing-Remitting Multiple Sclerosis Patients Under Immunocompromising Treatment. [PDF]

Int J Mol Sci
Cruces-Párraga J, Muñoz-Jurado A, Escribano BM, Martín-Hersog FA, Triguero-Ortiz C, Carmona-Medialdea C, Túnez I, Caballero-Villarraso J, Agüera-Morales E.   +8 more
europepmc   +1 more source

Comparative Efficacy of Ublitixumab Versus Natalizumab in the Treatment of Relapsing and Remitting Multiple Sclerosis. [PDF]

Cureus
Chitturi SV, Amith Priyansu J, Sadhu A, Ramisetty H, Pallapothu MR, Kogantii D.   +5 more
europepmc   +1 more source

Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis. [PDF]

J Neurol Neurosurg Psychiatry
Gelissen LMY, Toorop AA, Schipper PM, Hoitsma E, Zeinstra EMPE, van Rooij LC, van Munster CEP, Vennegoor A, Mostert J, Wokke B, Kalkers NF, Hoogervorst ELJ, van Eijk J, Roosendaal CM, Kragt JJ, Eurelings M, van Genugten J, Nielsen J, Sinnige LGF, Kloosterziel ME, Arnoldus EPJ, Bouvy WH, Strijbis EM, Oosten BV, De Jong BA, Uitdehaag BMJ, Lissenberg-Witte BI, Loeff FC, Rispens T, Killestein J, van Kempen ZLE.   +30 more
europepmc   +1 more source

Integrin β1 Demarks Precursors of Brain-Residing Antibody-Secreting Cells in Multiple Sclerosis. [PDF]

Neurol Neuroimmunol Neuroinflamm
Kuiper KL, Bogers L, Rip J, van Hasselt Y, Melief MJ, Wierenga-Wolf AF, Klein Kranenbarg RAM, Bindels E, van de Werken HJG, de Beukelaar J, Smets I, Wokke B, Smolders J, van Luijn MM.   +13 more
europepmc   +1 more source

Disproportionality analysis of drug-associated progressive multifocal leukoencephalopathy: roles of underlying diseases and immunomodulatory therapies in FAERS. [PDF]

Front Immunol
Lin X, Qin N, He B, Chen J, Zhang Y, Wang H, Liu W.   +6 more
europepmc   +1 more source

Access, satisfaction, adherence and safety to subcutaneous natalizumab compared to intravenous natalizumab in multiple sclerosis in a real-life cohort: first report from Latin America. [PDF]

Ther Adv Neurol Disord
Silva BA, Santajuliana F, Casas M, Lázaro L, Pita C, Cohen L, Rinaldi G, Alonso R, Míguez J, D'Alessandro S.   +9 more
europepmc   +1 more source

Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple Sclerosis. [PDF]

Eur J Neurol
Rosenstein I, Axelsson M, Johnsson M, Malmeström C, Kvartsberg H, Zetterberg H, Lycke J, Novakova L.   +7 more
europepmc   +1 more source

Comparative evaluation of STRATIFY JCV™ and IMMUNOWELL™ assays for anti-JCV antibody detection in natalizumab-treated RRMS patients. [PDF]

Ther Adv Neurol Disord
Chisari CG, Spampinato G, Crimì P, Ferraro E, Lo Fermo S, Cimino V, Zappia M, Patti F.   +7 more
europepmc   +1 more source

Targeting Neuroinflammation in Adult Ischemic Stroke: Direct Immunotherapy, Regenerative Cell-Based Strategies, and Translational Challenges-A Systematic Review with Exploratory Meta-analysis. [PDF]

Mol Neurobiol
Cera J, Krzyściak W.
europepmc   +1 more source

Experimental Therapies in Multiple Sclerosis: Epstein-Barr Virus and Potential EBV-Related Therapeutic Strategies-A Systematic Review. [PDF]

J Clin Med
Bartczak J, Gronowski P, Małek M, Denkiewicz A, Grodzka O, Chądzyński P, Domitrz I.   +6 more
europepmc   +1 more source